Wealth Enhancement Advisory Services
TNDM icon

Wealth Enhancement Advisory Services’s Tandem Diabetes Care TNDM Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407K Buy
26,438
+4,318
+20% +$75.4K ﹤0.01% 2889
2026
Q1 		$412K Buy
22,120
+3,427
+18% +$74.5K ﹤0.01% 2487
2025
Q4 		$440K Buy
18,693
+3,611
+24% +$65.2K ﹤0.01% 2580
2025
Q3 		$219K Buy
+15,082
New +$204K ﹤0.01% 3056

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Wealth Enhancement Advisory Services's TNDM Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Tandem Diabetes Care (TNDM) stake by 20% in Q2 2026, buying an estimated $75.4K and bringing the position to 26,438 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #2889.

Wealth Enhancement Advisory Services first reported a position in TNDM in Q3 2025 and has held it in 4 quarters since. The position peaked at $440K in Q4 2025. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Wealth Enhancement Advisory Services held 26,438 shares of Tandem Diabetes Care worth $407K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 4,318 Tandem Diabetes Care shares in Q2 2026, an estimated $75.4K.
  • Tandem Diabetes Care made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2889 holding.
  • Wealth Enhancement Advisory Services first reported a position in Tandem Diabetes Care in Q3 2025 and has held it in 4 quarters since.
  • Wealth Enhancement Advisory Services's Tandem Diabetes Care position peaked at $440K in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.